Birth Weight, Pregnancy, Vitamin D Deficiency
Conditions
Brief summary
The purpose of this study is to determine whether a daily supplement of vitamin D, taking before and during pregnancy, effects child birth weight, pre- and postpartum complication and bone mineral density during lactation.
Interventions
Cholecalciferol (Vitamin D3) oral 1 tablet 35 µg per day. Placebo oral 1 tablet per day. In total 35 µg per day. In total 2 tablets per day per participant from Baseline to 16 weeks after delivery.
placebo 2 tablet, once a day,
Cholecalciferol (Vitamin D3) oral 2 tablets each containing 35 µg. In total 70 µg per day. In total 2 tablets per day per participant from Baseline to 16 weeks after delivery.
Sponsors
Study design
Eligibility
Inclusion criteria
* P-OH25-vitamin D \< 50 nmol/l * Woman age 30-35 years * In good general health
Exclusion criteria
* Infertility * Intake of 400 IU or more Vitamin D/day * Cancer * Alcohol or drug abuse * Calciummetabolic disturbances * Spontaneous abortion within last 6 month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Birth Weight | 0-24 hours after delivery of the child |
Secondary
| Measure | Time frame |
|---|---|
| Post-partum effects of vitamin D supplement on maternal bone mineral density (BMD). | Day 1 to 4 months after delivery. |
| Infections of the newborn | Day 1 of the child to 16 weeks after birth. |
| Growth of the newborn measured by weight, crown-heel length and head circumference | Day 1 of the child to 16 weeks after birth |
| Time to accomplish pregnancy | 0-12 months |
Countries
Denmark